Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan.
Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases.
Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.
Sorafenib-induced interstitial pneumonitis in a patient with hepatocellular carcinoma: a case report.